R2 Capital Strategies’s Johnson & Johnson JNJ Stock Holding History

R2 Capital Strategies’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$292K	Buy	+1,148	New	+$268K	0.13%	100

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

R2 Capital Strategies's JNJ Position: Q2 2026 in Review

R2 Capital Strategies opened a new position in Johnson & Johnson (JNJ) in Q2 2026: 1,148 shares worth $292K. The stake represents 0.13% of the portfolio and ranks #100 among its holdings.

4,503 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

R2 Capital Strategies held 1,148 shares of Johnson & Johnson worth $292K as of Q2 2026.
Johnson & Johnson was a new R2 Capital Strategies position in Q2 2026.
Johnson & Johnson made up 0.13% of R2 Capital Strategies's portfolio in Q2 2026, its #100 holding.
4,503 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on R2 Capital Strategies's 13F filing for Q2 2026, filed 23 Jul 2026.